Emily E. Bernstein, PhD

Submitted by lisebram on
Author Photo
Emily E. Bernstein, PhD

Emily Bernstein completed her doctorate in clinical psychology at Harvard University and is now a Hope Fellow in psychology with the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital and Harvard Medical School. Her research centers on transdiagnostic mechanisms in the development and treatment of emotional disorders. Her work focuses on identifying modifiable causal mechanisms contributing to emotion dysregulation and developing novel interventions (e.g., brief interventions, digital tools, and health behaviors) to target these processes.

Rachel Yehuda, PhD

Submitted by lisebram on
Author Photo
Rachel Yehuda, PhD

Rachel Yehuda, PhD, is an Endowed Professor of Psychiatry and Neuroscience of Trauma.  She is also Director of Mental Health at the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies, PTSD, and intergenerational trauma.  In 2019, Dr. Yehuda was elected to the National Academy of Medicine for her seminal contributions to understanding the psychological and biological impact of traumatic stress.  In 2020, Dr.

Stephen Ross, MD

Submitted by lisebram on
Author Photo
Stephen Ross, MD

Dr. Stephen Ross is Research Associate Professor of Psychiatry and Child & Adolescent Psychiatry at the NYU Grossman School of Medicine. Dr. Ross is a founding member of the NYU Psychedelic Research Group and is currently associate director of the NYU Langone Health (NYULH) Center for Psychedelic Medicine and director of the NYULH Psychedelic Medicine Research Training Program. In 21 years at NYU and Bellevue, Dr Ross has been involved in a variety of leadership roles in administration, teaching and research.

Robin Carhart-Harris, PhD

Submitted by lisebram on
Author Photo
Robin Carhart-Harris, PhD

Robin Carhart-Harris, PhD is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry and Director Neuroscape’s Psychedelics Division at the University of California, San Francisco. He moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for severe mental illnesses. He has authored over 130 papers, with over forteen thousand citations.

Ashley Bramhall, MA

Submitted by lisebram on
Author Photo
Ashley Bramhall, MA

Ashley Bramhall earned her Master of Arts in Clinical Psychology from Pepperdine University, and as an MFT Trainee, Ashley began her training and specialization in the treatment of anxiety & OC spectrum disorders at Renewed Freedom Foundation. She continued to build on this expertise with specializations in children, teens, and athletes as an AMFT at Renewed Freedom Center for Rapid Anxiety Relief.

Jeff Cohen, PsyD

Submitted by lisebram on
Author Photo
Jeff Cohen, PsyD

Dr. Jeff Cohen, PsyD (he/him), is an Assistant Professor of Medical Psychology in Psychiatry at Columbia University, where he contributes to education, clinical care, and research, focusing particularly on the mental health of LGBTQ+ youth. Dr. Cohen teaches Abnormal Behavior and advanced courses in clinical psychology to undergraduates in the Department of Psychology at Columbia and instructs in Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) for psychiatry residents in the Department of Psychiatry. Dr.

Colleen A. Sloan, PhD

Submitted by lisebram on
Author Photo
Colleen A. Sloan, PhD

Colleen A. Sloan, PhD is a clinical psychologist at VA Boston Healthcare System and Assistant Professor of Psychiatry at Boston University School of Medicine. Dr. Sloan is involved both locally and nationally in education, training, and consultation in sexual and gender minority (SGM) health.  She has expertise in treatment for trauma-related problems and emotion dysregulation including Prolonged Exposure and Dialectical Behavior Therapy.